Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral 2 Aryl Propionate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110903189B details a cost-effective copper-catalyzed route for chiral 2-aryl propionates, offering significant supply chain advantages for NSAID intermediate manufacturing.